University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial

Get This Resource

English: Web site

Summary

Abstract. The full article is available with registration.

Publisher: Elsevier
Language: English
Format: Web site
Region: Global
Audiences: Doctors/Physicians, Researchers, Physician's Assistants/Nurse Practitioners
Topic Area: Pediatric Antiretroviral Treatment
Resource Type: Journal Articles